semaglutide recommended dose Dosing Schedule FDA alerts health care providers,

Interest in GLP-1 RAs has expanded because of their anti-inflammatory and anti-cancer effects, in addition to glucose control

Treatment recommendations are based on medical evaluation, clinical appropriateness, and provider judgment

Orforglipron shows what researchers call "biased signaling." It strongly activates the cAMP pathway while producing minimal activation of the beta-arrestin pathway

Patients who combine semaglutide with structured dietary support and regular physical activity often experience faster initial weight loss, typically 5-10 pounds within the first month as the medication suppresses appetite and increases satiety

Stopping semaglutide typically results in weight regain over 6-12 months, highlighting that ongoing treatment is often necessary to maintain results